Dinsmore Christopher 4
4 · Kronos Bio, Inc. · Filed Dec 14, 2022
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Dinsmore Christopher
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-12-12$1.81/sh−9,138$16,496→ 162,936 total
Footnotes (1)
- [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.